CALTX — Calliditas Therapeutics AB Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareMid Cap
- SEK5.53bn
- SEK5.53bn
- SEK1.21bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 754 | 996 | 956 | 1,249 | 974 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 49.3 | 22.8 | 11.3 | 88.7 | 197 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 821 | 1,037 | 1,013 | 1,412 | 1,275 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.06 | 5.41 | 39.6 | 31.9 | 54.2 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 845 | 1,506 | 1,460 | 1,953 | 1,859 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 53.4 | 106 | 135 | 325 | 407 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 57.1 | 296 | 452 | 1,187 | 1,524 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 788 | 1,210 | 1,008 | 766 | 335 |
Total Liabilities & Shareholders' Equity | 845 | 1,506 | 1,460 | 1,953 | 1,859 |
Total Common Shares Outstanding |